Lightpoint Medical, Ltd
Lightpoint Medical is a technology leader in targeted cancer surgery. We are developing miniaturized imaging and sensing tools for more precise intra-operative cancer detection. Our mission is to improve the lives of people with cancer by transforming the efficacy of minmally-invasive and robot-assisted procedures. Over recent decades, robots have transformed cancer surgery. However, in spite of the technological advances in robotic platforms, surgeons still remain completely dependent on their sight to detect cancer intra-operatively. As a result, surgeons often leave cancer behind or remove more healthy tissue than needed. Residual disease increases the need for further drug treatment, radiotherapy, and surgery. Similarly, removing healthy, functional tissue increases post-surgical complications and escalates healthcare costs. Lightpoint`s global network of sales distributors, as well as adding commercial insight into new product development.
At Lightpoint, we are optimizing the performance of minimally-invasive and robotic cancer surgery, by developing miniaturized imaging and sensing tools to accurately detect cancer intra-operatively. The aims of the tools are to aid surgical decision making, improve patient outcomes and save costs for healthcare system.
Lightpoint has a pipeline of miniaturized tools in development. The technologies incorporate recent advances in miniaturized sensors and detect cancer-targeted drugs already validated for whole-body imaging, such as SPECT/PET scans. The miniaturized probes aim to accurately identify cancer, enabling the full removal of diseased tissue, or confirm its absence, helping to preserve healthy, functional tissue. SENSEI® is our first robotic probe. Find out more in the video below.